Schrodinger, Inc. (SDGR) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Schrodinger reported revenue of $255.9M, up 23.3% from $207.5M the year before. Net income was -$103.3M (a -40.4% net margin), or -$1.41 per diluted share. Gross margin was 55.7% and operating margin was -65.2%. Operating activities generated $13.9M of cash, leaving $12.5M of free cash flow. At fiscal year end, Schrodinger held $726.2M in total assets against $362.1M in total liabilities, including $230.5M of cash and equivalents.
Open the full interactive Schrodinger financials → Quarterly statements, key ratios, valuation history and price charts.
Schrodinger Key Stats
| Share Price | $25.89 |
|---|---|
| Market Cap | $1.96B |
| Revenue YoY Growth | +23.3% |
| 52-Week Range | $11.07 – $32.60 |
| Shares Outstanding | 74.7 million (basic, 2026 Q2) |
Schrodinger Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $108.1M | $137.9M | $181.0M | $216.7M | $207.5M | $255.9M |
| Gross Profit | $63.5M | $65.6M | $101.0M | $140.7M | $132.1M | $142.6M |
| Operating Income | -$60.9M | -$111.4M | -$146.8M | -$177.4M | -$209.3M | -$166.9M |
| Pre-Tax Income | -$24.1M | -$100.0M | -$149.1M | $42.9M | -$185.7M | -$102.3M |
| Income Tax | $345,000 | $411,000 | $63,000 | $2.2M | $1.4M | $939,000 |
| Net Income | -$24.5M | -$100.4M | -$149.2M | $40.7M | -$187.1M | -$103.3M |
| Diluted EPS | -$0.41 | -$1.42 | -$2.10 | $0.54 | -$2.57 | -$1.41 |
Schrodinger Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $54.3M | $87.2M | $58.6M | $58.9M |
| Net Income | -$32.8M | $32.5M | -$60.0M | $6.0M |
| Diluted EPS | -$0.45 | $0.44 | -$0.81 | $0.08 |
Schrodinger Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $202.3M | $120.3M | $90.5M | $155.3M | $147.3M | $230.5M |
| Current Assets | $683.0M | $625.1M | $534.0M | $567.8M | $635.0M | $519.3M |
| Total Assets | $746.3M | $756.5M | $688.6M | $803.0M | $823.2M | $726.2M |
| Current Liabilities | $73.2M | $91.2M | $108.8M | $133.7M | $191.7M | $189.1M |
| Total Liabilities | $122.2M | $199.4M | $240.7M | $254.4M | $401.8M | $362.1M |
| Shareholders' Equity | $624.0M | $557.1M | $447.9M | $548.6M | $421.4M | $364.1M |
Schrodinger Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $16.8M | -$70.7M | -$119.7M | -$136.7M | -$157.4M | $13.9M |
| Cash From Investing | -$381.7M | -$16.8M | $90.0M | $193.0M | $148.8M | $57.9M |
| Cash From Financing | $541.3M | $8.0M | $2.1M | $9.0M | $10.1M | $2.9M |
| Free Cash Flow | $14.2M | -$77.8M | -$127.7M | -$150.1M | -$164.7M | $12.5M |
Figures from Schrodinger's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Schrodinger financials page for every line item.
Schrodinger Company Profile
| Ticker | SDGR |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001490978 |
Frequently Asked Questions
What was Schrodinger's revenue in fiscal 2025?
Schrodinger (SDGR) reported revenue of $255.9M for fiscal 2025.
What is Schrodinger's annual revenue history?
Schrodinger's annual revenue by fiscal year: 2020: $108.1M; 2021: $137.9M; 2022: $181.0M; 2023: $216.7M; 2024: $207.5M; 2025: $255.9M.
What was Schrodinger's net income in fiscal 2025?
Schrodinger reported net income of -$103.3M for fiscal 2025.
What was Schrodinger's earnings per share (EPS) in fiscal 2025?
Schrodinger's diluted EPS was -$1.41 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Schrodinger generate in fiscal 2025?
Schrodinger generated $12.5M of free cash flow in fiscal 2025.
What was Schrodinger's revenue last quarter?
In its most recent reported quarter (2026 Q2), Schrodinger reported revenue of $58.9M.
How many shares of Schrodinger are outstanding?
Schrodinger reported a weighted average of 74.7 million basic shares outstanding in 2026 Q2.
What is Schrodinger's market cap?
Based on its latest closing price, Schrodinger (SDGR) has a market capitalization of about $1.96B.
When does Schrodinger's fiscal year end?
Schrodinger's fiscal year end, as registered with the SEC, is December 31.
Where is Schrodinger headquartered?
Schrodinger lists its business address in New York, New York in its SEC filings.